SCHEMBL6638720

SCHEMBL6638720

Nc1nc(SCc2ccccn2)nc(Cl)c1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 4/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
CYP1A2 P05177 2/20 0.41
CYP2E1 P05181 2/20 0.41
CYP2C8 P10632 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2B6 P20813 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
ALDH1A1 P00352 3/20 0.41
PKM P14618 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
MAPT P10636 4/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636431 0.85 METAP2 (0.44) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL8140855 0.81 SMN1; SMN2 (0.41) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL6637738 0.80 METAP2 (0.48) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL9756602 0.76 RAB9A (0.60) SMN1; SMN2NPC1RAB9ACYP1A2CYP2E1
SCHEMBL6481832 0.76 ABCB1 (0.57) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL6640022 0.76 RAB9A (0.49) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL6640908 0.74 MEN1 (0.44) SMN1; SMN2NPC1RAB9ACYP1A2CYP2E1
SCHEMBL6639863 0.73 NPC1 (0.61) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL8137019 0.72 METAP2 (0.42) METAP2SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL8134818 0.72 SMN1; SMN2 (0.40) METAP2SMN1; SMN2NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1449835-A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds PHARMACIA & UPJOHN COMPANY (US) 2004-08-25 EP disclosed
EP-1247804-A1 Pyrimidine-thioalkyl and alkylether compounds PHARMACIA & UPJOHN COMPANY (US) 2002-10-09 EP disclosed
US-6043248-A VIRICIDES FOR TREATING AN INDIVIDUAL INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS PHARMACIA & UPJOHN COMPANY (US) 2000-03-28 US disclosed
US-5981537-A USEFUL IN THE TREATMENT OF INDIVIDUALS WHO ARE HIV POSITIVE PHARMACIA & UPJOHN COMPANY (US) 1999-11-09 US disclosed
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1998-02-25 EP disclosed
WO-1996035678-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1996-11-14 WO disclosed